Mode
Text Size
Log in / Sign up

Oropharyngeal squamous cell carcinoma

Part of Head and Neck Cancer

9 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Oropharyngeal squamous cell carcinoma

2 trials tracked for Oropharyngeal squamous cell carcinoma: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 64 citations.

2Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Other / NA 1
  1. Phase 3 Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Completed · 64 cited
  2. N/A The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Head and Neck Cancer

Related studies from across the Head and Neck Cancer family.

Post-operative ctDNA linked to worse survival in HPV-negative HNSCC, but estimate unstable
Oncology Meta-analysis
Post-operative ctDNA linked to worse survival in HPV-negative HNSCC, but estimate unstable ctDNA levels may signal cancer return in head and neck cancer
This meta-analysis examined post-operative ctDNA as a prognostic marker in HPV-negative head and neck squamous cell carcinoma. Detectable ct…
Detecting traces of cancer DNA in the blood after surgery may help identify patients at higher risk of cancer returning.
YAP and TAZ Overexpression Predicts Worse Survival in Oral Squamous Cell Carcinoma
Oncology Meta-analysis
YAP and TAZ Overexpression Predicts Worse Survival in Oral Squamous Cell Carcinoma Hippo Pathway Markers Linked to Oral Cancer Survival Rates
This meta-analysis of 17 studies examined the prognostic value of Hippo pathway effectors YAP and TAZ in oral squamous cell carcinoma. Poole…
New data suggests that specific proteins in the Hippo pathway may help predict survival outcomes for patients with oral squamous cell carcin…
Cisplatin Chemoradiotherapy for Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ENT (Otolaryngology) RCT
Cisplatin Chemoradiotherapy for Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck New trial tests chemotherapy for elderly patients with head cancer
This trial protocol describes a study evaluating the use of weekly cisplatin in elderly patients with locally advanced squamous cell carcino…
A new trial aims to see if adding a specific chemotherapy drug helps elderly patients with advanced head and neck cancer.
Response-adapted surgery after neoadjuvant immune checkpoint inhibitors improves pathologic complete response in mucosal HNSCC
ENT (Otolaryngology) Meta-analysis
Response-adapted surgery after neoadjuvant immune checkpoint inhibitors improves pathologic complete response in mucosal HNSCC Response-Adapted Surgery May Help Preserve Organs in Head Cancer
This meta-analysis of patients with resectable mucosal head and neck squamous cell carcinoma (HNSCC) found that response-adapted surgery (RA…
A new approach to surgery after immunotherapy may help patients with head and neck cancer keep more of their natural tissue and function.
Oral HPV reshapes mucosal microbial composition in a sex and population dependent manner
Infectious Disease Sys. Review
Oral HPV reshapes mucosal microbial composition in a sex and population dependent manner Oral and genital health linked to specific bacteria and HPV
This mini-review synthesizes evidence regarding the interaction between HPV infection and mucosal microbiota in oral, anorectal, and penile …
New research shows how specific bacteria and the HPV virus interact in the mouth and genital areas to influence cancer risk.
Evaluating Dose Escalation to 60 Gy in Locally Advanced Esophageal Squamous Cell Carcinoma
Drug Pipeline RCT
Evaluating Dose Escalation to 60 Gy in Locally Advanced Esophageal Squamous Cell Carcinoma Trial shows higher radiation dose does not improve cancer survival
A Phase 3 trial compares 60 Gy versus 50 Gy of radiotherapy with concurrent chemotherapy for patients with unresectable esophageal squamous …
A large trial shows that increasing radiation doses for advanced esophageal cancer does not improve survival but may increase side effects.
Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer
Oncology RCT
Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer Weekly cisplatin treatment shows promise for head and neck cancer
A randomized trial confirms that weekly cisplatin dosing achieves noninferiority in overall survival for high-risk squamous cell carcinoma p…
A new trial shows that giving chemotherapy weekly instead of every three weeks may offer a comparable survival rate for head and neck cancer…
SMMI framework provides a conceptual model for risk stratification in high-risk oral potentially malignant disorders
Oncology Meta-analysis
SMMI framework provides a conceptual model for risk stratification in high-risk oral potentially malignant disorders New Framework Helps Identify Risk of Oral Cancer Development
This evidence-ranked conceptual review proposes the spatial-microbial-metabolic-immune (SMMI) framework to study malignant transformation ri…
A new conceptual framework looks at how microbes and the immune system might help doctors better identify high risk for oral cancer developm…
Distinct microbial taxa and functional pathways are associated with oral squamous cell carcinoma
Oncology Meta-analysis
Distinct microbial taxa and functional pathways are associated with oral squamous cell carcinoma Specific Bacteria Linked to Oral Squamous Cell Carcinoma
This meta-analysis identifies specific microbial taxa and functional pathways associated with oral squamous cell carcinoma. The findings hig…
Researchers identified specific types of bacteria and genetic pathways that are more common in people with oral squamous cell carcinoma.
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways
Drug Pipeline Sys. Review
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways Plant extracts may slow growth of head and neck cancer
This systematic review examines the effects of plant extracts, including resveratrol, curcumin, quercetin, and anthocyanins, on head and nec…
Certain plant compounds like curcumin and resveratrol show promise in stopping cancer cell growth and resisting chemotherapy in lab studies.
Submental Artery Island Flap Shows 16% Pooled Locoregional Recurrence in Oral Cavity Reconstruction
ENT (Otolaryngology) Meta-analysis
Submental Artery Island Flap Shows 16% Pooled Locoregional Recurrence in Oral Cavity Reconstruction Submental artery island flap is a safe option for oral cancer
This meta-analysis pooled data on the submental artery island flap (SAIF) for oral cavity defects after oral squamous cell carcinoma resecti…
A specific surgical technique called the submental artery island flap shows a low recurrence rate for patients with oral cavity defects.
Impact of Perineural Invasion on Survival Outcomes in Oral Squamous Cell Carcinoma
ENT (Otolaryngology) Meta-analysis
Impact of Perineural Invasion on Survival Outcomes in Oral Squamous Cell Carcinoma Perineural invasion linked to poorer outcomes in oral squamous cell carcinoma
A meta-analysis of 23,580 patients confirms that perineural invasion is a potent independent predictor of poor survival and high recurrence …
A large review of over 23,000 patients shows that cancer cells spreading along nerves are linked to higher recurrence and lower survival rat…

Questions about Oropharyngeal squamous cell carcinoma

Do modern radiotherapy protocols improve symptoms for those with oropharyngeal squamous cell carcinoma?

Modern radiotherapy protocols for oropharyngeal squamous cell carcinoma have shown improvements in patient-reported outcomes, including fewer symptoms and lower levels of anxiety and depression.

Full answer →
What role does HPV play in the development of oropharyngeal squamous cell carcinoma?

HPV, especially type 16, drives most oropharyngeal squamous cell carcinomas through E6/E7 oncoproteins, which disable key tumor suppressors and lead to distinct, often more treatable tumors.

Full answer →